Syncanica’s focus is to bring novel, cannabinoid-based prescription medicines to patients in areas of serious unmet need and in which our medicines have the potential to make a real difference to their quality of life.
Incorporated in 2018 in Davis, California.
Meet the Team
Team of chemists and business development.
Mark Mascal, PhD
Founder & CEO
Fei Chang, PhD
Founder & Business Development